Previous studies have indicated that UbcH10 over-expression might be associated with the late stages of thyroid neoplastic transformation [3], and that high levels of UbcH10 correlate with most aggressive grade tumors in breast cancer [4]. Here, UBE2C is linked to breast cancer.